ProPhase Labs, Inc.
NASDAQ:PRPH
Overview | Financials
Company Name | ProPhase Labs, Inc. |
Symbol | PRPH |
Currency | USD |
Price | 1.43 |
Market Cap | 27,282,255 |
Dividend Yield | 0% |
52-week-range | 1.36 - 7.48 |
Industry | Drug Manufacturers—Specialty & Generic |
Sector | Healthcare |
CEO | Mr. Ted William Karkus |
Website | https://www.prophaselabs.com |
An error occurred while fetching data.
About ProPhase Labs, Inc.
ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Legendz XL
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD